Medical Research and Artificial Intelligence

Development of a Decision Support System for Exosome Therapy Dosing

A novel approach based on Agentic AI to support personalized treatment in Premature Ovarian Insufficiency (POI).

Exosome Therapy

Introduction to Exosome Therapy and Its Benefits

Exosome therapy is one of the novel and leading approaches in the field of stem cell-based therapies. In this method, instead of using stem cells directly, exosomes are utilized. Exosomes are extracellular vesicles secreted by these cells, responsible for transmitting biological messages and stimulating tissue repair and regeneration processes.

Strategic Advantage in POI Treatment

Due to having many of the benefits of cell therapy while reducing some of its limitations and risks (such as unwanted immune reactions), this method has been proposed as a highly promising option for treating various diseases, including Premature Ovarian Insufficiency (POI).

Challenges and the Necessity of Using AI

Despite the high potential of exosome therapy, this field is still emerging. Existing clinical studies are limited, and comprehensive, standardized knowledge regarding the determination of the optimal therapeutic dose for patients with different physiological conditions is incomplete.

The Issue of Clinical Uncertainty

In such circumstances, where physicians face a lack of precise dosing protocols, advanced AI technologies can play a significant role in aggregating and analyzing existing knowledge and supporting sensitive therapeutic decisions.

Agent-Based Decision Support System Approach

The main goal of this research is to develop an advanced decision support system based on Agentic AI for determining the exosome therapy dose in patients with Premature Ovarian Insufficiency.

How the System Works:

Step One: Knowledge Processing and Aggregation
The system extracts and structures the limited clinical information and evidence available in medical literature and databases.
Step Two: Patient Profile Analysis
Smart agents review and evaluate the physiological conditions, medical history, and biomarkers of each POI patient.
Step Three: Reasoning and Dose Recommendation
Utilizing logical reasoning capabilities, the smart agent recommends the appropriate exosome dose tailored to the patient’s specific conditions and presents its reasoning to the physician.

Achievements and Future Prospects

This research is expected to pave new paths in medical science by effectively using the analytical power of smart agents:

01

Reducing Uncertainty

Improving the therapeutic dosing process and reducing errors caused by guesswork in complex medical decision-making.

02

Personalized Treatment

Developing and promoting exosome-based Personalized Medicine, perfectly tailored to each patient’s needs and conditions.

03

Accelerating Clinical Application

A major step toward deploying the next generation of agent-based smart systems in medicine, accelerating the development of clinical applications in modern therapies.

Avatar photo
تیم تولید محتوای مبنا Website

Comments closed.